| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/12/2002 | US20020128283 Process improvement in the preparation of (4R, 5S, 6S)-3-[[(2R,3R)-2-[[[(S)-2-amino-3-methyl-1-oxobutyl]amino]methyl]tetrahydro-3-furanyl]thio]-6-[(R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid |
| 09/12/2002 | US20020128282 Method of improving bioavailability of orally administered drugs, a method of screening for enhancers of such bioavailability and novel pharmaceutical compositions for oral delivery of drugs |
| 09/12/2002 | US20020128280 Administering (1) a farnesyl protein transferase inhibitor and (2) a tyrosine kinase inhibitor. |
| 09/12/2002 | US20020128279 Potassium channel blocking agents |
| 09/12/2002 | US20020128278 Inhibit some of the ill effects caused by diabetes or by aging; preventing premature aging, rheumatoid arthritis, Alzheimer's disease, uremia, neurotoxicity, atherosclerosis and spoilage of proteins in food |
| 09/12/2002 | US20020128277 Modulators of KCNQ potassium channels and use thereof in treating migraine and mechanistically related diseases |
| 09/12/2002 | US20020128276 Administering an estrogen agonist/ antagonist; lowering vaginal pH; treating an urinary tract infection; treating vaginal dryness, itching, undesired spasms, and vaginitis; treating undesired urinary frequency or incontinence |
| 09/12/2002 | US20020128273 Composition and method for treating the effects of diseases and maladies |
| 09/12/2002 | US20020128271 N-benzenesulfonyl l-proline compounds as bradykinin antagonists |
| 09/12/2002 | US20020128270 Treating stroke, arhtritis, cancer, tissue ulceration, decubitis ulcer, restenosis, periodontal disease, epidermolysis bullosa, scleritis, psoriasis, AIDS, sepsis, and septic shock. |
| 09/12/2002 | US20020128268 Cosmetic and dermatological preparations; use in nutrition or consumption |
| 09/12/2002 | US20020128267 Especially celecoxib, deracoxib, valdecoxib, a benzopyran COX-2 inhibitor, parecoxib, rofecoxib etoricoxib, or a 2-(3,5-difluorophenyl)-3-(4-(methylsulfonyl)phenyl) -substituted cyclopentenone, or pyridazinone |
| 09/12/2002 | US20020128266 ABCA-1 elevating compounds |
| 09/12/2002 | US20020128265 CRF receptor antagonists and methods relating thereto |
| 09/12/2002 | US20020128264 Methods for treatment of conditions affected by activity of multidrug transporters |
| 09/12/2002 | US20020128263 Treatment or prevention of mGluR5 receptor mediated disorders. |
| 09/12/2002 | US20020128262 Styrylbenzodiazepines |
| 09/12/2002 | US20020128261 Cyclohepta [b] [1,4] diazepino [6,7, 1-hi] indoles and derivatives |
| 09/12/2002 | US20020128259 Using a vasopressin antagonist such as conivaptan |
| 09/12/2002 | US20020128258 Therapeutical method involving subcutaneous administration of drugs containing cephalotaxine derivatives |
| 09/12/2002 | US20020128257 2-benzazipine derivative; antineoplastic, antitumor, antiinflammatory and antimetastasis agents |
| 09/12/2002 | US20020128256 Methods for the treatment or prevention of inflammatory diseases characterized by abnormal cell proliferation |
| 09/12/2002 | US20020128255 Substituted hydroxyl amine derivatives; inhibitors of beta-secretase, inhibit beta-secretase-mediated cleavage, inhibitors of A beta production, and/or are effective to reduce amyloid beta deposits or plaques |
| 09/12/2002 | US20020128254 Antibiotics, bactericides |
| 09/12/2002 | US20020128253 Diphenylazetidinone derivatives, process for their preparation, medicaments comprising these compounds and their use |
| 09/12/2002 | US20020128252 Diphenylazetidinone derivatives, process for their preparation, medicaments comprising these compounds and their use |
| 09/12/2002 | US20020128250 Modulating the expression of a gene |
| 09/12/2002 | US20020128249 Phthalocyanine analogs |
| 09/12/2002 | US20020128248 Superoxide dismutase mimetics (SODm), manganese complex of a heterocyclic pentaazacyclopentadecane ligand as antiarthritic agents |
| 09/12/2002 | US20020128247 Phenyl sulfamide derivatives as dietetics, antidiabetics, and hypotensive agents |
| 09/12/2002 | US20020128246 Regulation of intracellular glucocorticoid concentrations |
| 09/12/2002 | US20020128245 Using a 11 beta-reductase inhibitor in the manufacture of a medicament for control of 11-keto steroid conversion to 11 beta-hydroxysteroid in vivo |
| 09/12/2002 | US20020128244 Regulation of intracellular glucocorticoid concentrations |
| 09/12/2002 | US20020128243 Administering a polycyclic sulfamate ester that is replaced with a sulfate group and incubated with a seroid sulphatase enzyme at 7.4 pH and 37 degrees C to provide a Km value of < 50 micrometers |
| 09/12/2002 | US20020128242 Novel cationic cholesteryl derivatives containing cyclic polar groups |
| 09/12/2002 | US20020128241 Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease |
| 09/12/2002 | US20020128240 Treatment of hyperproliferative diseases using active vitamin D analogues |
| 09/12/2002 | US20020128239 > 1 x 10-7 mole per liter of a vitamin D compound in an acceptable lipid; anticancer agents |
| 09/12/2002 | US20020128238 7-phenyl-substituted tetracycline compounds |
| 09/12/2002 | US20020128236 Substituted fused pyrroleoximes and fused pyrazoleoximes |
| 09/12/2002 | US20020128235 Contacting a tissue or cell with (Z)-1-(N-(3-Ammoniopropyl)-N-(n-propyl)amino) diazen-ium-1,2-diolate or a derivative |
| 09/12/2002 | US20020128230 Neutrophil function inhibitors |
| 09/12/2002 | US20020128229 Treating symptoms of menopause; improves water solubility of drospirenone |
| 09/12/2002 | US20020128228 Compositions and methods for the treatment of cancer |
| 09/12/2002 | US20020128227 Beta-cyclodextrin compositions, and use to prevent transmission of sexually transmitted diseases |
| 09/12/2002 | US20020128226 Enoxaparin and methods of its use |
| 09/12/2002 | US20020128225 Methods and products related to pulmonary delivery of polysaccharides |
| 09/12/2002 | US20020128224 Administering a nucleoside 5'-pyrophosphate pyranoside or analogue, of given formula |
| 09/12/2002 | US20020128223 Methods for modulating the axonal outgrowth of central nervous system neurons |
| 09/12/2002 | US20020128220 Testosterone-repressed prostate message-2 (TRPM-2); delaying progression of prostatic tumor cells to an androgen-independent state |
| 09/12/2002 | US20020128218 Therapeutic delivery compositions and methods of use thereof |
| 09/12/2002 | US20020128217 Therapeutic use of cis-element decoys in vivo |
| 09/12/2002 | US20020128216 Antisense oligonucleotides and peptide nucleic acids for treating asthma or an eosinophilic syndrome |
| 09/12/2002 | US20020128214 C-glucosyl ether lipids |
| 09/12/2002 | US20020128211 A chromanol glycoside, such as 2-(alpha-D-glucopyranosyl)methyl-2,5,7,8- tetramethyl chroman-6-ol |
| 09/12/2002 | US20020128210 Treating a fungal or yeast infection such as with betulin, allobetulin, and lupeol |
| 09/12/2002 | US20020128203 Methods of identifying inhibitory compounds and uses thereof |
| 09/12/2002 | US20020128195 Hydrophilic polymer covalently and reversibly linked to amine-containing ligand through dithiobenzyl linkage; improves blood circulation time |
| 09/12/2002 | US20020128191 Topical administration of ophthalmic preparations of bactericidal/permeability-increasing (BPI) protein to reduce hyperemia, chemosis, mucous discharge, neovascularization or ulcer formation |
| 09/12/2002 | US20020128184 Ubiquinone composition and methods related thereto |
| 09/12/2002 | US20020128183 Gene regulation therapy involving ferritin |
| 09/12/2002 | US20020128178 Use of a growth hormone or a growth hormone secretagogue for promoting bone formation in an animal simultaneous with callus distraction |
| 09/12/2002 | US20020128176 Treatment of erectile dysfunctions with C-Type natriuretic polypeptide (CNP) as a monotherapy or in combination with phosphodiesterase inhibitors |
| 09/12/2002 | US20020128173 Method of treating or preventing migraine headaches |
| 09/12/2002 | US20020128172 Use of 5-HT4 modulators for the manufacture of a medicament for the treatment of the bladder diseases |
| 09/12/2002 | US20020128171 Administering to the mammal a therapeutically effective amount of a compound that increases nitric oxide (NO) activity as measured in a standard gastric emptying assay |
| 09/12/2002 | US20020127713 Specific tolerance in transplantation |
| 09/12/2002 | US20020127698 Serpin drugs for treatment of HIV infection and method of use thereof |
| 09/12/2002 | US20020127694 2786, a novel human aminopeptidase |
| 09/12/2002 | US20020127676 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 09/12/2002 | US20020127668 Polypeptide for use in the diagnosis and treatment of cancer, nervous system and vessicular transport disorders |
| 09/12/2002 | US20020127634 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
| 09/12/2002 | US20020127612 Cell proliferation polypeptide for use in the diagnosis and treatment of tumors |
| 09/12/2002 | US20020127605 Cyclophilin compound for use in the treatment of infections, nervous system, skin, ischemic and vision disorders |
| 09/12/2002 | US20020127596 murF2 |
| 09/12/2002 | US20020127558 Genetic polymorphism of MxA protein and use thereof |
| 09/12/2002 | US20020127553 Apoptin-associating protein |
| 09/12/2002 | US20020127544 Kit for the detection of modulator which prevent viral diseases |
| 09/12/2002 | US20020127542 Pharmaceutical compositions for treating tumour diseases |
| 09/12/2002 | US20020127536 Mitochondrial assay |
| 09/12/2002 | US20020127319 Composition containing xylitol and fiber |
| 09/12/2002 | US20020127303 Used for multivitamin tablets, hard gelatin capsules, dry food and feed compositions and for enriching sugar |
| 09/12/2002 | US20020127287 Administering biologically active lipophilic ginkgolides and derivatives and food ingredient modulating phospholipid metabolism for protecting neuronal cells for therapy and prophylaxis of mental or neuronal disorders |
| 09/12/2002 | US20020127281 Stabilized hyrogen peroxide solutions |
| 09/12/2002 | US20020127278 Dissolving the organic compound in the water-miscible first solvent to form a solution, mixing solution with second solvent to define a pre-suspension; adding energy to the pre-suspension to form particles |
| 09/12/2002 | US20020127277 Solid dosage forms of divalproex sodium |
| 09/12/2002 | US20020127275 Slow release pharmaceutical compositions and methods of preparation |
| 09/12/2002 | US20020127274 Method of making ibuprofen and narcotic analgesic compositions |
| 09/12/2002 | US20020127273 Liposomal nystatin treatment of fungal infection |
| 09/12/2002 | US20020127272 For use as delivery vehicles for biologically active molecules |
| 09/12/2002 | US20020127271 Formulation for the treatment and/or prophylaxis of dementia |
| 09/12/2002 | US20020127268 Palatability to ruminants, does not reduce feed intake by mother animals before parturition |
| 09/12/2002 | US20020127267 Method and product for treating cancer in pets |
| 09/12/2002 | US20020127256 Compositions and methods for treating dermatological disorders |
| 09/12/2002 | US20020127255 For conditioning skin, stability |
| 09/12/2002 | US20020127254 Devices for local and systemic delivery of active substance and methods of manufacturing thereof |
| 09/12/2002 | US20020127253 Stable hydroalcoholic compositions |
| 09/12/2002 | US20020127252 Using compounds such as 2,5,7,8-tetramethyl-2-( beta -carboxyethyl)-6-hydroxychroman in cosmetic or dermatological preparations for prophylaxis against dry skin, wrinkle formation and/or pigment disorders |
| 09/12/2002 | US20020127250 Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
| 09/12/2002 | US20020127249 Novel formulation for use in pain management |